Company intelligence / Profile preview

Omeopiacenza

Piacenza, Emilia-Romagna, Italy

Ownership: Private
Development stage: Other

Overview

PharmExtracta S.p.A (resulting from the merger of Omeopiacenza Srl and PharmExtracta Srl) offers innovative pharmaceutical and nutraceutical products validated by published clinical studies. Their portfolio covers advanced solutions in phytotherapy and probiotics, with commercialized products widely available in Italy.

Therapeutic areas: ImmunologyMetabolic DisordersOtherGastroenterology
Modalities: Small moleculeHerbal extractProbioticNutraceutical
Industry: Biotech

Beyond the preview

Go deeper on Omeopiacenza.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omeopiacenza.

Explore the full profile